Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Disease, Chronic Obstructive | 8 | 2025 | 164 | 1.440 |
Why?
|
| Sarcoidosis | 4 | 2020 | 11 | 0.800 |
Why?
|
| Hospitals, Teaching | 1 | 2021 | 33 | 0.700 |
Why?
|
| Seasons | 1 | 2021 | 133 | 0.670 |
Why?
|
| Comorbidity | 2 | 2017 | 723 | 0.650 |
Why?
|
| Lung | 4 | 2025 | 484 | 0.640 |
Why?
|
| Hospital Mortality | 1 | 2021 | 205 | 0.620 |
Why?
|
| Teaching Rounds | 1 | 2019 | 4 | 0.600 |
Why?
|
| Diagnostic Techniques, Respiratory System | 1 | 2017 | 2 | 0.540 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2017 | 14 | 0.540 |
Why?
|
| Referral and Consultation | 1 | 2017 | 140 | 0.500 |
Why?
|
| Medicaid | 1 | 2017 | 138 | 0.460 |
Why?
|
| Telemedicine | 1 | 2019 | 214 | 0.460 |
Why?
|
| Socioeconomic Factors | 2 | 2007 | 1221 | 0.230 |
Why?
|
| Humans | 21 | 2025 | 42113 | 0.230 |
Why?
|
| Middle Aged | 10 | 2025 | 11790 | 0.220 |
Why?
|
| Respiratory Function Tests | 1 | 2024 | 61 | 0.210 |
Why?
|
| Airway Obstruction | 1 | 2024 | 9 | 0.210 |
Why?
|
| United States | 4 | 2021 | 5068 | 0.200 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2002 | 5 | 0.190 |
Why?
|
| Intensive Care Units | 2 | 2021 | 71 | 0.190 |
Why?
|
| Hospitalization | 1 | 2006 | 477 | 0.190 |
Why?
|
| Retrospective Studies | 4 | 2021 | 2466 | 0.190 |
Why?
|
| Critical Care | 1 | 2002 | 48 | 0.190 |
Why?
|
| Diagnosis, Differential | 2 | 2017 | 236 | 0.170 |
Why?
|
| Respiratory Insufficiency | 1 | 2021 | 15 | 0.170 |
Why?
|
| Adult | 7 | 2024 | 13437 | 0.170 |
Why?
|
| Radiography, Thoracic | 1 | 2000 | 12 | 0.170 |
Why?
|
| Vaccines | 1 | 2021 | 64 | 0.170 |
Why?
|
| Sarcoidosis, Pulmonary | 1 | 2020 | 2 | 0.160 |
Why?
|
| Male | 11 | 2025 | 22745 | 0.160 |
Why?
|
| Liver Diseases | 1 | 2020 | 34 | 0.160 |
Why?
|
| Spirometry | 3 | 2025 | 40 | 0.160 |
Why?
|
| Length of Stay | 1 | 2021 | 229 | 0.160 |
Why?
|
| Internship and Residency | 1 | 2021 | 141 | 0.160 |
Why?
|
| Forced Expiratory Volume | 3 | 2025 | 75 | 0.160 |
Why?
|
| Prognosis | 2 | 2024 | 847 | 0.150 |
Why?
|
| Postoperative Complications | 1 | 2021 | 253 | 0.150 |
Why?
|
| Depressive Disorder, Major | 1 | 2021 | 128 | 0.150 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 63 | 0.150 |
Why?
|
| Female | 9 | 2025 | 23980 | 0.140 |
Why?
|
| Erythrocyte Transfusion | 1 | 2018 | 19 | 0.140 |
Why?
|
| Kidney Diseases | 1 | 2020 | 170 | 0.140 |
Why?
|
| Smoking | 3 | 2023 | 1019 | 0.140 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 1058 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2025 | 244 | 0.130 |
Why?
|
| Hospitals, University | 1 | 2017 | 39 | 0.130 |
Why?
|
| International Cooperation | 1 | 2017 | 51 | 0.130 |
Why?
|
| Cohort Studies | 2 | 2023 | 1728 | 0.130 |
Why?
|
| Malaria, Falciparum | 1 | 2018 | 91 | 0.130 |
Why?
|
| Clinical Competence | 1 | 2017 | 154 | 0.120 |
Why?
|
| Quality of Health Care | 1 | 2017 | 158 | 0.120 |
Why?
|
| Anemia, Sickle Cell | 1 | 2018 | 185 | 0.120 |
Why?
|
| Dyspnea | 2 | 2025 | 23 | 0.110 |
Why?
|
| Vital Capacity | 2 | 2025 | 44 | 0.110 |
Why?
|
| Quality of Life | 2 | 2025 | 598 | 0.100 |
Why?
|
| Disease Progression | 2 | 2025 | 660 | 0.100 |
Why?
|
| Adolescent | 3 | 2021 | 5949 | 0.100 |
Why?
|
| Cross-Sectional Studies | 3 | 2024 | 3073 | 0.090 |
Why?
|
| Emphysema | 1 | 2012 | 6 | 0.090 |
Why?
|
| Longitudinal Studies | 2 | 2025 | 1019 | 0.080 |
Why?
|
| Multiple Organ Failure | 2 | 2018 | 8 | 0.080 |
Why?
|
| Incidence | 2 | 2021 | 1052 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2025 | 1051 | 0.080 |
Why?
|
| Poliovirus | 1 | 1988 | 5 | 0.070 |
Why?
|
| Picornaviridae | 1 | 1988 | 4 | 0.070 |
Why?
|
| Genes | 1 | 1988 | 56 | 0.070 |
Why?
|
| Genes, Viral | 1 | 1988 | 64 | 0.070 |
Why?
|
| Peptide Hydrolases | 1 | 1988 | 44 | 0.070 |
Why?
|
| Radiography | 1 | 2007 | 71 | 0.070 |
Why?
|
| Protein Biosynthesis | 1 | 1988 | 136 | 0.060 |
Why?
|
| Observer Variation | 2 | 2012 | 58 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2007 | 541 | 0.060 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1988 | 184 | 0.060 |
Why?
|
| Polycythemia | 1 | 2006 | 15 | 0.060 |
Why?
|
| Scleroderma, Systemic | 1 | 2006 | 12 | 0.060 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2006 | 13 | 0.060 |
Why?
|
| Viral Proteins | 1 | 1988 | 196 | 0.060 |
Why?
|
| Young Adult | 1 | 2017 | 4928 | 0.060 |
Why?
|
| Sex Distribution | 1 | 2006 | 224 | 0.060 |
Why?
|
| Age Distribution | 1 | 2006 | 249 | 0.060 |
Why?
|
| Aged | 4 | 2025 | 7958 | 0.060 |
Why?
|
| Pulmonary Emphysema | 1 | 2025 | 13 | 0.060 |
Why?
|
| Bronchitis, Chronic | 1 | 2025 | 16 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 704 | 0.050 |
Why?
|
| Phenotype | 1 | 2006 | 774 | 0.050 |
Why?
|
| Precipitating Factors | 1 | 2002 | 3 | 0.050 |
Why?
|
| Plasmapheresis | 1 | 2002 | 3 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2024 | 437 | 0.050 |
Why?
|
| Risk Factors | 2 | 2011 | 3933 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2019 | 1265 | 0.050 |
Why?
|
| Nutrition Surveys | 1 | 2024 | 263 | 0.050 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 46 | 0.040 |
Why?
|
| Critical Illness | 1 | 2021 | 46 | 0.040 |
Why?
|
| Algorithms | 1 | 2024 | 508 | 0.040 |
Why?
|
| Pulmonary Medicine | 1 | 2020 | 4 | 0.040 |
Why?
|
| Endosonography | 1 | 2020 | 6 | 0.040 |
Why?
|
| Mediastinum | 1 | 2020 | 6 | 0.040 |
Why?
|
| Aspartate Aminotransferases | 1 | 2020 | 15 | 0.040 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2020 | 12 | 0.040 |
Why?
|
| Bronchoscopy | 1 | 2020 | 7 | 0.040 |
Why?
|
| Alanine Transaminase | 1 | 2020 | 26 | 0.040 |
Why?
|
| Hypercalcemia | 1 | 2020 | 13 | 0.040 |
Why?
|
| Alkaline Phosphatase | 1 | 2020 | 53 | 0.040 |
Why?
|
| Eye Diseases | 1 | 2020 | 26 | 0.040 |
Why?
|
| Creatinine | 1 | 2020 | 102 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2020 | 73 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2020 | 74 | 0.040 |
Why?
|
| Biopsy | 1 | 2020 | 176 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2020 | 93 | 0.040 |
Why?
|
| Vaccination | 1 | 2021 | 332 | 0.040 |
Why?
|
| Hypertension, Pulmonary | 1 | 2020 | 78 | 0.040 |
Why?
|
| Echocardiography | 1 | 2020 | 167 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2020 | 183 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 570 | 0.040 |
Why?
|
| Vitamin D | 1 | 2020 | 196 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2024 | 702 | 0.030 |
Why?
|
| Antimalarials | 1 | 2018 | 63 | 0.030 |
Why?
|
| Calcium | 1 | 2020 | 487 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 575 | 0.030 |
Why?
|
| Depression | 1 | 2021 | 837 | 0.030 |
Why?
|
| Education | 1 | 2012 | 60 | 0.020 |
Why?
|
| Linear Models | 1 | 2011 | 310 | 0.020 |
Why?
|
| Research Design | 1 | 2012 | 370 | 0.020 |
Why?
|
| Age Factors | 1 | 2011 | 1135 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1988 | 168 | 0.020 |
Why?
|
| Prevalence | 1 | 2012 | 1593 | 0.020 |
Why?
|
| DNA Replication | 1 | 1988 | 153 | 0.020 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2006 | 18 | 0.020 |
Why?
|
| Headache | 1 | 2006 | 21 | 0.020 |
Why?
|
| Vision, Low | 1 | 2006 | 13 | 0.020 |
Why?
|
| Erythropoietin | 1 | 2006 | 36 | 0.020 |
Why?
|
| Virus Replication | 1 | 1988 | 318 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 2790 | 0.010 |
Why?
|